Online Program

Relationship between contraceptive use and HIV testing in sub-Saharan Africa

Sunday, November 1, 2015

Katherine Center, PhD, Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ
Jayleen Gunn, PhD, MPH, Department of Epidemiology, University of Arizona, Tucson, AZ
Ibitola Asaolu, MPH, University of Arizona, Tucson, AZ
Steven Gibson, B.S., University of Arizona, Tucson
Echezona Ezeanolue, MD, MPH, Department of Pediatrics, Nevada Care Program, University of Nevada School of Medicine in Las Vegas, Reno, NV
John Ehiri, PhD, Department of Health Promotion Sciences, University of Arizona, Mel & Enid Zuckerman College of Public Health, Tucson, AZ
background: Recent evidence points to a significant increase in the number of sexual partners in many African countries. Additionally, less than half of the world’s HIV positive population knows their HIV status, inadvertently putting more individuals at risk of acquiring HIV and other sexually transmitted infections (STIs). This study evaluated the relationship between contraceptive use and the uptake of HIV testing in sub-Saharan Africa.

methods: Data was derived from the Demographic and Health Survey by combining information from 4 unique African countries: Uganda, Nigeria, Congo and Mozambique. These countries were chosen due to their geographical locations across the continent. The relationship between each contraceptive method and uptake of HIV testing was adjusted by participants’ characteristics (i.e., age, marital status, education, urban/rural residence and number of children in the household) using logistic regression.

results: After adjustment, individuals who participated in HIV testing had an increase in the odds of using the following contraceptive methods: pill (AOR=2.05; 95%CI: 1.85, 2.28), diaphragm (AOR= 2.19; 1.97, 2.44), hysterectomy (AOR= 1.19; 1.11, 1.27), male sterilization (AOR= 1.45; 1.01, 2.07), and abstinence (AOR= 2.08; 1.28, 3.34).  A significant reduction in uptake of HIV testing was associated with withdrawal (AOR= 0.57; 0.53, 0.62) and Norplant (AOR= 0.43; 0.35, 0.51). No association was seen with use of male condoms during previous intercourse or intrauterine devices.

conclusion: Women could benefit from an integrated approach to family planning and HIV counseling and testing. This is especially important in women who use withdrawal and Norplant as their contraceptive methods.

Learning Areas:

Assessment of individual and community needs for health education
Diversity and culture
Public health or related education

Learning Objectives:
Discuss the role of contraceptive use on update of HIV testing is sub-Saharan Africa.

Keyword(s): HIV/AIDS, Sexuality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the lead author on this project. Among my scientific interests is women's health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.